
Muzamil Arshad, MD/PhD
@muzamilarshad18
Rad Onc @ UChicago #RadOnc @ #UChicago | Research interests: Radio genomics, Personalized RT, MRI, Immunology | Tweets are my own. Link to Blog is below.
ID: 1052328026493673473
https://arshadmuzamil92.wixsite.com/scienceandmedicine 16-10-2018 22:38:47
1,1K Tweet
260 Followers
439 Following



Scientists have identified disease-associated properties of #CD8+ T cells in early and definitive stages of #MultipleSclerosis, which could serve as potential targets for therapeutics. Learn more in Science Immunology: bit.ly/3XJWCvW






Most viewed in the last 7 days from JAMA Oncology: Prostate cancer treatment was associated with higher rates of complications in the 12 years after treatment, even after accounting for age-related symptoms and disease. ja.ma/3Cv3eri



Check out the latest from UChicagoCancerCenter HN Group - the DEPEND trial. 1) There is strong interest in determining how to incorporate immunotherapy into non-operative management for LA-HNSCC to improve outcomes for high risk HPV-negative patients.




Had the opportunity of a lifetime to meet with fellow veteran, Hoosier and former Secretary of Transportation Pete Buttigieg. While the conversation was off the record, I was struck by how thoughtful, kind, and genuinely committed he is to making our country better.Pete Buttigieg


Terrific visit today from UMich Rad Onc 's Dr. Ted Lawrence, pictured here with our Rad Onc residents.


Facts and hopes in radioimmunotherapy of oligometastatic disease aacrjournals.org/clincancerres/… Excellent review by University of Chicago Radiation Oncology residents Daniel Huang and Connor Lynch Ralph Weichselbaum UChicagoCancerCenter


